ContextEvery year approximately 2 million US women are diagnosed as having a cervical
cytological result of atypical squamous cells of undetermined significance (ASC-US) …

Background: More than 2 million US women receive an equivocal cervical cytologic
diagnosis (atypical squamous cells of undetermined significance [ASCUS]) each year …

Objective This study was undertaken to compare alternative strategies for the initial
management of a cytologic diagnosis of atypical squamous cells of undetermined …

ObjectiveTo provide evidence-based consensus guidelines for the management of women
with cervical cytological abnormalities and cervical cancer precursors. ParticipantsA panel of …

Background: The ALTS (atypical squamous cells of undetermined significance ASCUS and
low-grade squamous intraepithelial lesion LSIL Triage Study) suggests that, for women …

OBJECTIVE: To determine whether women in the National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) who had findings on a Papanicolaou (Pap) test of atypical …

OBJECTIVE: To investigate the relative performances of follow-up cytology and carcinogenic
human papillomavirus (HPV) DNA testing among carcinogenic HPV-negative women with …

BACKGROUND Current guidelines recommend colposcopy rather than high‐risk human
papillomavirus (HPV) testing for the evaluation of abnormal cervical cytology interpreted as …

Abstract BACKGROUND The 2001 Bethesda System category of atypical squamous cells
(ASC) denotes changes suggestive, but inconclusive for, a squamous intraepithelial lesion …

The objective of our study was to assess the performance of different triage strategies for
high‐risk human papillomavirus (hrHPV)‐positive results utilizing either extended …